Literature DB >> 16763989

Very late thrombosis after drug-eluting stents.

Fausto Feres1, J Ribamar Costa, Alexandre Abizaid.   

Abstract

Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary disease. Its occurrence after drug eluting stent (DES) placement has raised concerns, especially when it occurs late after the stent implantation. The mechanisms of late thrombosis after DES have yet to be completely understood. By means of serial angiography and intravascular (IVUS) images we described a relatively new and unusual vessel response to drug-eluting stents (e.g. huge positive remodeling in all vessel extension), leading to impressive late-acquired incomplete stent apposition and finally causing stent thrombosis and acute myocardial infarction. After describing the two cases, one after Cypher stent implantation and one after Taxus stent implantation, we briefly reviewed the literature available on stent thrombosis with special emphasis on its late occurrence. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763989     DOI: 10.1002/ccd.20692

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  13 in total

1.  A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study).

Authors:  Jacek Legutko; Wojciech Zasada; Grzegorz L Kałuża; Grzegorz Heba; Lukasz Rzeszutko; Jacek Jakala; Jacek Dragan; Artur Klecha; Dawid Giszterowicz; Wojciech Dobrowolski; Lukasz Partyka; Swaminathan Jayaraman; Dariusz Dudek
Journal:  Indian Heart J       Date:  2013-07-21

2.  Long-term outcomes of patients receiving drug-eluting stents.

Authors:  Andrew C Philpott; Danielle A Southern; Fiona M Clement; P Diane Galbraith; Mouhieddin Traboulsi; Merril L Knudtson; William A Ghali
Journal:  CMAJ       Date:  2008-12-18       Impact factor: 8.262

3.  Recurrent very late thrombosis of drug-eluting stent: Optical coherence tomography findings.

Authors:  Nobuaki Kobayashi; Masamichi Takano; Noritake Hata; Masanori Yamamoto; Takuro Shinada; Yasuhiro Takahashi; Kazunori Tomita; Mitsunobu Kitamura; Osamu Kurihara; Kyoichi Mizuno
Journal:  J Cardiol Cases       Date:  2010-08-10

4.  The dawn of neurosurgery in pre-conquest Mesoamerican territories.

Authors:  Graciela Zuccaro
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

Review 5.  Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.

Authors:  J Carlsson; B von Wagenheim; R Linder; T M Anwari; J Qvist; I Petersson; T Magounakis; B Lagerqvist
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

6.  [Coronary stent thrombosis: what's new in 2011?].

Authors:  M Oberhänsli; S Puricel; M Togni; S Cook
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

7.  A chemical stability study of trimethylsilane plasma nanocoatings for coronary stents.

Authors:  John Eric Jones; Qingsong Yu; Meng Chen
Journal:  J Biomater Sci Polym Ed       Date:  2016-10-19       Impact factor: 3.517

8.  Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation.

Authors:  Pritam Patil; Arvind Sethi; Upendra Kaul
Journal:  Indian Heart J       Date:  2014-03-27

9.  Preclinical evaluation of a novel abluminal surface coated sirolimus eluting stent with biodegradable polymer matrix.

Authors:  Prakash Sojitra; Manish Doshi; Marco Galloni; Christina Vignolini; Ashwin Vyas; Bhavesh Chevli; Imad Sheiban
Journal:  Cardiovasc Diagn Ther       Date:  2015-08

10.  Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial.

Authors:  J Ribamar Costa; Daniel Chamié; Alexandre A C Abizaid; Expedito Ribeiro; George C Meireles; Maurício Prudente; Carlos A Campos; Juliana P Castro; Ricardo Costa; Pedro A Lemos
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-06       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.